Mona Ashiya

General Partner, OrbiMed

Mona Ashiya, PhD, is a General Partner of OrbiMed since 2010. Prior to OrbiMed, Mona covered the biotechnology industry as a member of J.P. Morgan’s biotechnology equity research team. Her previous experience includes positions at the Global Alliance for TB Drug Development and the Harvard Business School.

Dr. Ashiya earned a BA degree from the University of California at Berkeley, a PhD in cellular, molecular, and developmental biology from the University of Pittsburgh, and was a post-doctoral fellow at the Dana Farber Cancer Institute.